scholarly journals Efficacy and Safety of Electronic Cigarettes as a Smoking Cessation Intervention: A Systematic Review and Network Meta-Analysis

2020 ◽  
Author(s):  
Joan Mary Quigley ◽  
Cathal Walsh ◽  
Caitriona Lee ◽  
Jean Long ◽  
Helen Kennelly ◽  
...  
Keyword(s):  
Systematic Review ◽  
Smoking Cessation ◽  
Electronic Cigarettes ◽  
Meta Analysis ◽  
Smoking Cessation Intervention ◽  
Efficacy And Safety ◽  
Cessation Intervention

scholarly journals Re-starting smoking in the postpartum period after receiving a smoking cessation intervention: a systematic review

Addiction ◽  
2016 ◽  
Vol 111 (6) ◽  
pp. 981-990 ◽  
Author(s):  
Matthew Jones ◽  
Sarah Lewis ◽  
Steve Parrott ◽  
Stephen Wormall ◽  
Tim Coleman
Keyword(s):  
Systematic Review ◽  
Smoking Cessation ◽  
Postpartum Period ◽  
Smoking Cessation Intervention ◽  
Cessation Intervention

scholarly journals Effectiveness of Electronic Cigarettes in Smoking Cessation: A Systematic Review and Meta-analysis

2020 ◽  
Author(s):  
Igor Grabovac ◽  
Moritz Oberndorfer ◽  
Jismy Fischer ◽  
Winfried Wiesinger ◽  
Sandra Haider ◽  
...  
Keyword(s):  
Systematic Review ◽  
Smoking Cessation ◽  
Random Effects ◽  
Electronic Cigarettes ◽  
Meta Analysis ◽  
Current Evidence ◽  
Quality Of Evidence ◽  
Registration Number ◽  
Meta Analyses

Abstract Introduction Reports of the effectiveness of e-cigarettes (ECs) for smoking cessation vary across different studies making implementation recommendations hard to attain. We performed a systematic review and meta-analysis to assess the current evidence regarding effectiveness of ECs for smoking cessation. Methods PubMed, PsycInfo, and Embase databases were searched for randomized controlled trials comparing nicotine ECs with non-nicotine ECs or with established smoking cessation interventions (nicotine replacement therapy [NRT] and or counseling) published between 1 January 2014 and 27 June 2020. Data from eligible studies were extracted and used for random-effects meta-analyses (PROSPERO registration number: CRD42019141414). Results The search yielded 13 950 publications with 12 studies being identified as eligible for systematic review (N = 8362) and 9 studies for random-effects meta-analyses (range: 30–6006 participants). The proportion of smokers achieving abstinence was 1.71 (95 CI: 1.02–2.84) times higher in nicotine EC users compared with non-nicotine EC users. The proportion of abstinent smokers was 1.69 (95 CI: 1.25–2.27) times higher in EC users compared with participants receiving NRT. EC users showed a 2.04 (95 CI: 0.90–4.64) times higher proportion of abstinent smokers in comparison with participants solely receiving counseling. Conclusions Our results suggest that nicotine ECs may be more effective in smoking cessation when compared with placebo ECs or NRT. When compared with counseling alone, nicotine ECs are more effective short term, but its effectiveness appears to diminish with later follow-ups. Given the small number of studies, heterogeneous design, and the overall moderate to low quality of evidence, it is not possible to offer clear recommendations. Implications The results of this study do not allow for a conclusive argument. However, pooling current evidence points toward a potential for ECs as a smoking cessation tool. Though, given the overall quality of evidence, future studies should aim for more clarity in terms of interventions and larger study populations.

A Systematic Review of Smoking Cessation Intervention Studies in China

2012 ◽  
Vol 14 (8) ◽  
pp. 891-899 ◽  
Author(s):  
Sun S. Kim ◽  
Wei Chen ◽  
Monika Kolodziej ◽  
Xue Wang ◽  
Victoria J. Wang ◽  
...  
Keyword(s):  
Systematic Review ◽  
Smoking Cessation ◽  
Intervention Studies ◽  
Smoking Cessation Intervention ◽  
Cessation Intervention

scholarly journals Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis

2010 ◽  
Vol 196 (5) ◽  
pp. 346-353 ◽  
Author(s):  
Daniel Tai-yin Tsoi ◽  
Mamta Porwal ◽  
Angela Claire Webster
Keyword(s):  
Systematic Review ◽  
Smoking Cessation ◽  
Negative Symptoms ◽  
Meta Analysis ◽  
Current Evidence ◽  
Smoking Abstinence ◽  
Efficacy And Safety ◽  
End Of Treatment ◽  
Significant Difference ◽  
Randomised Controlled

BackgroundThe benefits and harms of bupropion as an aid for smoking cessation in schizophrenia remain uncertain.AimsTo summarise the current evidence for efficacy and safety of bupropion as treatment for nicotine dependence in schizophrenia.MethodSystematic review and random-effects meta-analysis of randomised controlled trials (RCTs) comparing bupropion with placebo or alternative therapeutic control in adult smokers with schizophrenia.ResultsTwenty-one reports from seven RCTs were included. Biochemically verified self-reported smoking cessation rates after bupropion were significantly higher than placebo at the end of treatment (risk ratio (RR) = 2.57, P = 0.004) and at 6 months (RR = 2.78, P = 0.05). Expired carbon monoxide level was significantly lower with bupropion at the end of therapy (P = 0.002) but not at 6 months (P = 0.37). There was no significant difference in positive (P = 0.28) or negative symptoms (P = 0.49) between the bupropion and the placebo group.ConclusionsBupropion increases the rates of smoking abstinence in smokers with schizophrenia, without jeopardising their mental state.

Sign in / Sign up

Export Citation Format

Share Document